To further evaluate the role of endogenous Nox4 in the development of CAVD in vivo, we used a global tamoxifen-inducible Nox4 knockout (Nox4KO) mouse model bred on an ApoE−/− background, as previously described.30 The gene discussed is APOE; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.